Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome
Condition(s):Myelodysplastic SyndromeLast Updated:June 23, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Myelodysplastic SyndromeLast Updated:June 23, 2017Completed
Condition(s):Myelodysplastic Syndromes; MDS; RAEB; Chronic Myelomonocytic LeukemiaLast Updated:June 30, 2020Completed
Condition(s):Myelodysplastic Syndrome; Acute Myeloid LeukemiaLast Updated:June 26, 2017Completed
Condition(s):Ovarian CancerLast Updated:July 21, 2017Completed
Condition(s):Myelodysplastic SyndromeLast Updated:June 26, 2017Completed
Condition(s):Acute Myelocytic Leukemia; Acute Lymphocytic Leukemia; Chronic Myelocytic Leukemia; Chronic Lymphocytic Leukemia; Myelodysplastic SyndromesLast Updated:January 10, 2018Completed
Condition(s):Malignant Neoplasmas; Solid TumorsLast Updated:June 23, 2017Completed
Condition(s):Advanced Cancer; Solid Tumors; Cancer; NeoplasmsLast Updated:June 23, 2017Completed
Condition(s):Solid Tumors; Advanced Cancer; Cancer; NeoplasmsLast Updated:June 23, 2017Completed
Condition(s):Head and Neck Squamous Cell Carcinoma; Anal Squamous Cell Carcinoma; Lung Squamous Cell Carcinoma; Cervical Squamous Cell Carcinoma; Esophageal Squamous Cell Carcinoma; Skin Squamous Cell Carcinoma; Penile Squamous Cell CarcinomaLast Updated:June 26, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.